Observational, non-interventional, multicenter study of adverse events in hemodialysis patients receiving ESA (erythropoiesis-stimulating agents) originators or biosimilars (ESAVIEW -View on erythropoiesis-stimulating agents)

29/05/2014
01/04/2024
EU PAS number:
EUPAS5711
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information
Publications